Innovation within reach.
Investing in PAVmed is investing in innovation that has the potential to impact and even transform healthcare. Stay informed about the latest news and updates from our team.
PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. Veris is concurrently developing an implantable physiological monitor, designed to be implanted alongside a chemotherapy port, which will interface with the Veris Cancer Care Platform. Its other subsidiary, Lucid Diagnostics Inc. (NASDAQ: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer to prevent esophageal cancer deaths.
Latest News & Updates
CONTACT US
Get in touch.
Interested in collaborating or looking for more information about our innovations, events, products or partnerships? Connect with us.
CONTACTInvestor Updates
Email Alerts
Sign up for our investor mailing list below to receive the latest news and financials form PAVmed delivered to your inbox.